Insider · CIK 0002050755
Reprogrammed Interchange LLC
Files at VOR (Vor Biopharma Inc.). First filing Aug 27, 2025, latest Oct 21, 2025.
In brief
Reprogrammed Interchange LLC files SEC Form 4 as 10% owner at VOR (Vor Biopharma Inc.). Since Aug 27, 2025, Reprogrammed Interchange LLC has reported 0 open-market buys worth $0 and 12 open-market sells worth $28M, the latest filed on Oct 21, 2025.
A track record needs three past buys with six months of prices behind them; Reprogrammed Interchange LLC has 0, so none is measured yet.
The newest scored trade: sold $1.1M of VOR on Oct 17, 2025, filed Oct 21, 2025, scored 45 (moderate). In the last 12 months: 0 buys worth $0 and 3 sells worth $6.5M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VOR: Vor Biopharma Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Vor Biopharma Inc. | $1.1M 37,533 shares | -3% | +860% from low-46% from high | |
| 45Moderate | Vor Biopharma Inc. | $2.3M 73,676 shares | -6% | +901% from low-43% from high | |
| 45Moderate | Vor Biopharma Inc. | $3.0M 96,657 shares | -7% | +934% from low-42% from high | |
| 45Moderate | Vor Biopharma Inc. | $4.1M 124,146 shares | -8% | +1006% from low-37% from high | |
| 45Moderate | Vor Biopharma Inc. | $3.6M 98,387 shares | -6% | +1082% from low-33% from high | |
| 45Moderate | Vor Biopharma Inc. | $1.6M 41,752 shares | -3% | +1200% from low-26% from high | |
| 33Weak | VORsell Vor Biopharma Inc. | $689k 447,278 shares | -1% | +940% from low-41% from high | |
| 37Weak | VORsell Vor Biopharma Inc. | $1.7M 984,805 shares | -3% | +1102% from low-32% from high | |
| 37Weak | VORsell Vor Biopharma Inc. | $2.5M 1,263,647 shares | -4% | +1211% from low-26% from high | |
| 37Weak | VORsell Vor Biopharma Inc. | $2.8M 1,407,628 shares | -4% | +1225% from low-25% from high | |
| 37Weak | VORsell Vor Biopharma Inc. | $2.8M 1,417,998 shares | -4% | +1225% from low-25% from high | |
| 37Weak | VORsell Vor Biopharma Inc. | $1.4M 671,536 shares | -2% | +1264% from low-23% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 3, 2025 | VOR Vor Biopharma Inc. | 23,000,000 18.16% of outstanding | $46M | Sep 3, 2025 | none |
Transactions
Every row this insider has filed, 44 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 17, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -24,689 | $30.22 | $746k | 1,179,753 | Oct 21, 2025 |
| Oct 17, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -1,028 | $31.00 | $32k | 1,178,725 | Oct 21, 2025 |
| Oct 20, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -11,616 | $30.05 | $349k | 1,167,109 | Oct 21, 2025 |
| Oct 21, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -200 | $30.08 | $6,015 | 1,166,909 | Oct 21, 2025 |
| Oct 15, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -14,851 | $31.05 | $461k | 1,263,267 | Oct 17, 2025 |
| Oct 15, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -48,910 | $32.05 | $1.6M | 1,214,357 | Oct 17, 2025 |
| Oct 15, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -7,894 | $32.77 | $259k | 1,206,463 | Oct 17, 2025 |
| Oct 16, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -2,021 | $30.45 | $62k | 1,204,442 | Oct 17, 2025 |
| Oct 10, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -40,983 | $30.97 | $1.3M | 1,333,792 | Oct 15, 2025 |
| Oct 13, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -19,672 | $32.36 | $637k | 1,314,120 | Oct 15, 2025 |
| Oct 13, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -2,334 | $33.09 | $77k | 1,311,786 | Oct 15, 2025 |
| Oct 14, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -33,668 | $30.32 | $1.0M | 1,278,118 | Oct 15, 2025 |
| Oct 8, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -60,926 | $33.75 | $2.1M | 1,437,995 | Oct 10, 2025 |
| Oct 8, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -14,336 | $34.34 | $492k | 1,423,659 | Oct 10, 2025 |
| Oct 9, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -33,842 | $31.92 | $1.1M | 1,389,817 | Oct 10, 2025 |
| Oct 9, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -15,042 | $32.41 | $487k | 1,374,775 | Oct 10, 2025 |
| Oct 6, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -17,760 | $36.00 | $639k | 1,579,548 | Oct 8, 2025 |
| Oct 6, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -34,847 | $37.12 | $1.3M | 1,544,701 | Oct 8, 2025 |
| Oct 6, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -18,156 | $37.77 | $686k | 1,526,545 | Oct 8, 2025 |
| Oct 7, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -27,624 | $33.84 | $935k | 1,498,921 | Oct 8, 2025 |
| Oct 1, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -1,400 | $39.19 | $55k | 1,637,660 | Oct 3, 2025 |
| Oct 2, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -4,937 | $37.21 | $184k | 1,632,723 | Oct 3, 2025 |
| Oct 2, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -1,513 | $38.38 | $58k | 1,631,210 | Oct 3, 2025 |
| Oct 2, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -7,700 | $39.57 | $305k | 1,623,510 | Oct 3, 2025 |
| Oct 2, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -13,001 | $40.13 | $522k | 1,610,509 | Oct 3, 2025 |
| Oct 2, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -5,300 | $42.32 | $224k | 1,605,209 | Oct 3, 2025 |
| Oct 3, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -3,200 | $37.37 | $120k | 1,602,009 | Oct 3, 2025 |
| Oct 3, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -4,701 | $38.14 | $179k | 1,597,308 | Oct 3, 2025 |
| Sep 16, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -447,278 | $1.54 | $689k | 32,781,209 | Sep 18, 2025 |
| Sep 11, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -284,805 | $1.83 | $521k | 33,928,487 | Sep 15, 2025 |
| Sep 12, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -300,000 | $1.75 | $526k | 33,628,487 | Sep 15, 2025 |
| Sep 15, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -400,000 | $1.64 | $656k | 33,228,487 | Sep 15, 2025 |
| Sep 8, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -464,421 | $1.99 | $924k | 35,012,518 | Sep 10, 2025 |
| Sep 9, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -449,226 | $2.00 | $899k | 34,563,292 | Sep 10, 2025 |
| Sep 10, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -350,000 | $1.82 | $635k | 34,213,292 | Sep 10, 2025 |
| Sep 3, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -554,612 | $2.00 | $1.1M | 36,329,955 | Sep 5, 2025 |
| Sep 4, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -453,016 | $1.93 | $874k | 35,876,939 | Sep 5, 2025 |
| Sep 5, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -400,000 | $1.97 | $787k | 35,476,939 | Sep 5, 2025 |
| Aug 27, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -611,647 | $2.01 | $1.2M | 37,690,918 | Aug 29, 2025 |
| Aug 28, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -806,351 | $2.01 | $1.6M | 36,884,567 | Aug 29, 2025 |
| Aug 25, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -387,346 | $2.12 | $820k | 38,586,755 | Aug 27, 2025 |
| Aug 26, 2025 | VOR Vor Biopharma Inc. | SOpen-market sale Common Stock | -284,190 | $2.08 | $591k | 38,302,565 | Aug 27, 2025 |
| Dec 30, 2024 | VOR Vor Biopharma Inc. | POpen-market purchase Common Stock | +38,974,101 | - | - | 38,974,101 | Jan 2, 2025 |
| Dec 30, 2024 | VOR Vor Biopharma Inc. | POpen-market purchase Warrant (Right to Buy)derivative | +48,717,626 | - | - | 48,717,626 | Jan 2, 2025 |
Questions about Reprogrammed Interchange LLC
Answered from the filings on this page, as of the latest one.
Is Reprogrammed Interchange LLC buying or selling?
In the last 12 months Reprogrammed Interchange LLC reported 0 open-market buys worth $0 and 3 open-market sells worth $6.5M on SEC Form 4; the latest was sold $1.1M of VOR on Oct 17, 2025. Grants, option exercises and tax withholding are not counted.
How did Reprogrammed Interchange LLC's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Reprogrammed Interchange LLC has 0.
Where does Reprogrammed Interchange LLC file Form 4?
Reprogrammed Interchange LLC has filed Form 4 at VOR (Vor Biopharma Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.